Diane Heditsian

451 total citations
11 papers, 20 citations indexed

About

Diane Heditsian is a scholar working on Cancer Research, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Diane Heditsian has authored 11 papers receiving a total of 20 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Cancer Research, 3 papers in Molecular Biology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Diane Heditsian's work include Medical Imaging Techniques and Applications (2 papers), Salivary Gland Disorders and Functions (2 papers) and Ethics in Clinical Research (2 papers). Diane Heditsian is often cited by papers focused on Medical Imaging Techniques and Applications (2 papers), Salivary Gland Disorders and Functions (2 papers) and Ethics in Clinical Research (2 papers). Diane Heditsian collaborates with scholars based in United States and Sweden. Diane Heditsian's co-authors include Susie Brain, Tess A. O’Meara, Jane Perlmutter, Laura Esserman, Christina Curtis, Ella F. Jones, Dawn L. Hershman, Alexandra Thomas, Martin Eklund and Rita Nanda and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Annals of Oncology.

In The Last Decade

Diane Heditsian

7 papers receiving 20 citations

Peers

Diane Heditsian

ONCOL

RNMI

PHYSI

Nils Rouven Hansmeier Germany

А. Б. Песков Russia

Sara Penchev United States

N Egoroff Australia

Heidi Dowst United States

Ana Nogués Pevidal Spain

Caterina Vita Italy

Hugo Hool United States

Jiaxin Zhong China

E. Suzanna Indonesia

Nils Rouven Hansmeier Germany

Diane Heditsian

7 ×0.9

9 ×1.3

8 ×1.1

ONCOL

2 ×0.7

RNMI

4 ×1.3

PHYSI

Citations per year, relative to Diane Heditsian Diane Heditsian (= 1×) peers Nils Rouven Hansmeier

Countries citing papers authored by Diane Heditsian

Since Specialization

Citations

This map shows the geographic impact of Diane Heditsian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diane Heditsian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diane Heditsian more than expected).

Fields of papers citing papers by Diane Heditsian

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Diane Heditsian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diane Heditsian. The network helps show where Diane Heditsian may publish in the future.

Co-authorship network of co-authors of Diane Heditsian

This figure shows the co-authorship network connecting the top 25 collaborators of Diane Heditsian. A scholar is included among the top collaborators of Diane Heditsian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Diane Heditsian. Diane Heditsian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Diwanji, Devan, Natsuko Onishi, Courtney Lawhn-Heath, et al.. (2024). ¹⁸F-FDG Dedicated Breast PET Complementary to Breast MRI for Evaluating Early Response to Neoadjuvant Chemotherapy. Radiology Imaging Cancer. 6(2). e230082–e230082.

Sharma, Anukriti, Tess A. O’Meara, Maribel Campos, et al.. (2024). Gut and oral microbial compositional differences in women with breast cancer, women with ductal carcinoma in situ , and healthy women. mSystems. 9(11). e0123724–e0123724. 5 indexed citations

Naeim, Arash, Lisa Madlensky, Susie Brain, et al.. (2024). Receiving a Pathogenic Variant in a Population Breast Cancer Screening Trial: A Mixed Method Study. Public Health Genomics. 27(1). 177–196.

Huppert, Laura A., David S. Wolf, Christina Yau, et al.. (2024). Pathologic complete response (pCR) rates for patients with HR+/HER2− high-risk, early-stage breast cancer (EBC) by clinical and molecular features in the phase II I-SPY2 clinical trial. Annals of Oncology. 36(2). 172–184. 7 indexed citations

Basu, Amrita, Thomas Jones, Timothy D. Brown, et al.. (2023). 374P Evaluation of symptom severity, tolerability, and physical function in the I-SPY2 trial. Annals of Oncology. 34. S332–S333. 1 indexed citations

Perlmutter, Jane, Susie Brain, Deborah Collyar, et al.. (2023). Advocate involvement in Clinical Trials: Lessons from the Patient-centric I-SPY2 Breast Cancer Trial. Medical Research Archives. 11(7.2). 2 indexed citations

Jacob, Saya, Zoe Quandt, Michelle Melisko, et al.. (2023). Delayed immune toxicities in patients with breast cancer receiving immune checkpoint inhibitors.. Journal of Clinical Oncology. 41(16_suppl). e24091–e24091.

Brain, Susie, Diane Heditsian, Vivian Lee, et al.. (2022). Patient perspectives on window of opportunity clinical trials in early-stage breast cancer. Breast Cancer Research and Treatment. 194(1). 171–178.

Jones, Ella F., David C. Newitt, Courtney Lawhn-Heath, et al.. (2022). Abstract P3-02-01: Initial experience of FES-dedicated breast PET imaging of early-stage ER+ invasive lobular carcinoma. Cancer Research. 82(4_Supplement). P3–2. 1 indexed citations

10.

Huang, Weilin, Susie Brain, Diane Heditsian, et al.. (2020). Rationale, Study Design, and Cohort Characteristics for the Markers for Environmental Exposures (MEE) Study. International Journal of Environmental Research and Public Health. 17(5). 1774–1774. 3 indexed citations

11.

Campbell, Michael J., et al.. (2019). Abstract 2830: Breast cancer and the human oral and gut microbiomes. Cancer Research. 79(13_Supplement). 2830–2830. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact